Journal article
2020
APA
Click to copy
Hernández-Morales, R., Cruz-González, A. Ã. A.-C. Ã. A., Ãlvarez-Carreño, C., Becerra, A., Campillo-Balderas, J. Ã. A. C.-M. Ã. A., Córdova-Villalba, G., … Lazcano, A. (2020). A Note on the Potential Clinical Use of Sofosbuvir to Treat COVID-19: The Importance of Protease Inhibitors.
Chicago/Turabian
Click to copy
Hernández-Morales, R., Adrián Aguilar-Cámara Abelardo Cruz-González, Claudia Ãlvarez-Carreño, A. Becerra, José Alberto Cisneros-MartÃnez Alejandro Campillo-Balderas, Grisel Córdova-Villalba, W. Cottom-Salas, et al. “A Note on the Potential Clinical Use of Sofosbuvir to Treat COVID-19: The Importance of Protease Inhibitors” (2020).
MLA
Click to copy
Hernández-Morales, R., et al. A Note on the Potential Clinical Use of Sofosbuvir to Treat COVID-19: The Importance of Protease Inhibitors. 2020.
BibTeX Click to copy
@article{r2020a,
title = {A Note on the Potential Clinical Use of Sofosbuvir to Treat COVID-19: The Importance of Protease Inhibitors},
year = {2020},
author = {Hernández-Morales, R. and Cruz-González, Adrián Aguilar-Cámara Abelardo and Ãlvarez-Carreño, Claudia and Becerra, A. and Campillo-Balderas, José Alberto Cisneros-MartÃnez Alejandro and Córdova-Villalba, Grisel and Cottom-Salas, W. and Cruz-González, Coral and Jácome, R. and Miranda-Pérez, Ingrid and Muñoz-Velasco, Israel and Quintero-Navarro, Luis Alonso and Rivas, Mario and Cabañas, Noel and Sánchez-Rocha, Alma Carolina and Vázquez-Salazar, A. and de León, Samuel Ponce and Lazcano, A.}
}
In this manuscript we argue that the use of Sofosbuvir as a possible medication in the clinical treatment of COVID-19 can be complemented with HCV protease inhi